Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 26, Issue 4, Pages 459-468
Publisher
Wiley
Online
2016-09-10
DOI
10.1002/pds.4107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty
- (2016) Kristian B. Filion et al. DIABETES CARE
- A Multicenter Observational Study of Incretin-based Drugs and Heart Failure
- (2016) Kristian B. Filion et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Point: Incident Exposures, Prevalent Exposures, and Causal Inference: Does Limiting Studies to Persons Who Are Followed From First Exposure Onward Damage Epidemiology?
- (2015) Jan Vandenbroucke et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Incretin-Based Drugs and the Risk of Congestive Heart Failure
- (2014) Oriana Hoi Yun Yu et al. DIABETES CARE
- Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
- (2014) M. Gokhale et al. DIABETES OBESITY & METABOLISM
- Performance of time-dependent propensity scores: a pharmacoepidemiology case study
- (2014) Wayne A. Ray et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Time-dependent propensity score and collider-stratification bias: an example of beta2-agonist use and the risk of coronary heart disease
- (2013) M. Sanni Ali et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment Dynamics of Newly Marketed Drugs and Implications for Comparative Effectiveness Research
- (2013) Joshua J. Gagne et al. VALUE IN HEALTH
- Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
- (2013) Rikke Sørensen et al. BMJ Open
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- The incident user design in comparative effectiveness research
- (2012) Eric S. Johnson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Long-term effects of insulin glargine on the risk of breast cancer
- (2011) S. Suissa et al. DIABETOLOGIA
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II
- (2009) Emily Cox et al. VALUE IN HEALTH
- Effectiveness of combination therapies in asthma: An observational study
- (2008) Samy Suissa et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search